Study of ONTAK (Denileukin Diftitox) in Cutaneous T-Cell Lymphoma (CTCL) Patients

Clinical trial NCT00050999 · COMPLETED

Trial details

NCT number: NCT00050999
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Lymphoma, T-Cell, Cutaneous Mycosis Fungoides Sezary Syndrome

Start date: 1995-06-01
Primary completion: 2006-09-01
Enrollment: 195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.